Skip to main content
Fig. 4 | BMC Pharmacology and Toxicology

Fig. 4

From: Risk comparison of adverse reactions between gemcitabine monotherapy and gemcitabine combined with albumin-bound paclitaxel in pancreatic cancer: insights from the FDA Adverse Event Reporting System (FAERS) database

Fig. 4

The time to onset and weibull distribution analysis of AEs among two treatment groups. (a) Time to onset for G treatment-related AEs (b) Time to onset for AG treatment-related AEs (c) The box plot, histogram and weibull distribution of onset time for G treatment-related AEs (d) The box plot, histogram and weibull distribution of onset time for AG treatment-related AEs. Abbreviations AEs, adverse events; WSP, weibull shape parameter; 95% CI, confidence interval; IQR, interquartile range; G treatment, gemcitabine monotherapy; AG treatment, gemcitabine combined with albumin-bound paclitaxel

Back to article page

BMC Pharmacology and Toxicology

ISSN: 2050-6511

Contact us